Wahida A, Buschhorn L, Fröhling S, Jost PJ, Schneeweiss A, Lichter P, et al. The coming decade in precision oncology: six riddles. Nat Rev Cancer. 2023;23:43–54. https://doi.org/10.1038/s41568-022-00529-3
Article CAS PubMed Google Scholar
Chen P, Liu Y, Wen Y, Zhou C. Non‐small cell lung cancer in China. Cancer Commun. 2022;42:937–70. https://doi.org/10.1002/cac2.12359
Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B, et al. Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer. 2023;22:1–37. https://doi.org/10.1186/s12943-023-01740-y
Ge F, Li Y, Yuan T, Wu Y, He Q, Yang B, et al. Deubiquitinating enzymes: promising targets for drug resistance. Drug Discov Today. 2022;27:2603–13. https://doi.org/10.1016/j.drudis.2022.06.009
Article CAS PubMed Google Scholar
Kim SJ, Puranik N, Yadav D, Jin JO, Lee PCW. Lipid nanocarrier-based drug delivery systems: therapeutic advances in the treatment of lung cancer. Int J Nanomedicine. 2023;18:2659–76. https://doi.org/10.2147/ijn.S406415
Article CAS PubMed PubMed Central Google Scholar
Fan M, Shan M, Lan X, Fang X, Song D, Luo H, et al. Anticancer effect and potential microRNAs targets of ginsenosides against breast cancer. Front Pharmacol. 2022;13:1033017–29. https://doi.org/10.3389/fphar.2022.1033017
Article CAS PubMed PubMed Central Google Scholar
Zhao X, Liu J. Chemical constituents from the fruits of Ligustrum lucidum W.T. aiton and their role on the medicinal treatment. Nat Prod Commun. 2020;15:1–12. https://doi.org/10.1177/1934578x20922338
Asma ST, Acaroz U, Imre K, Morar A, Shah SRA, Hussain SZ, et al. Natural products/bioactive compounds as a source of anticancer drugs. Cancers. 2022;14:6203–26. https://doi.org/10.3390/cancers14246203
Article CAS PubMed PubMed Central Google Scholar
Salvador JAR, Leal AS, Valdeira AS, Gonçalves BMF, Alho DPS, Figueiredo SAC, et al. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: recent advances in cancer treatment. Eur J Med Chem. 2017;142:95–130. https://doi.org/10.1016/j.ejmech.2017.07.013
Article CAS PubMed Google Scholar
Pantia S, Kangsamaksin T, Janvilisri T, Komyod W. Asiatic acid inhibits nasopharyngeal carcinoma cell viability and migration via suppressing STAT3 and Claudin-1. Pharmaceuticals. 2023;16:1–14. https://doi.org/10.3390/ph16060902
Hsu YL, Kuo PL, Lin LT, Lin CC. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathgways in human breast cancer cells. J Pharmacol Exp Ther. 2005;313:333–44. https://doi.org/10.1124/jpet.104.078808
Article CAS PubMed Google Scholar
Cheng Q, Zhang S, Zhong B, Chen Z, Peng F. Asiatic acid re-sensitizes multidrug-resistant A549/DDP cells to cisplatin by down regulating long non-coding RNA metastasis associated lung adenocarcinoma transcript 1/β-catenin signaling. Bioengineered. 2022;13:12972–84. https://doi.org/10.1080/21655979.2022.2079302
Article CAS PubMed PubMed Central Google Scholar
Ren Y, Kinghorn AD. Natural product triterpenoids and their semi-synthetic derivatives with potential anticancer activity. Planta Med. 2019;85:802–14. https://doi.org/10.1055/a-0832-2383
Article CAS PubMed PubMed Central Google Scholar
Diniz LR, Calado LL, Duarte AB, de Sousa DP. Centella asiatica and its metabolite asiatic acid: wound healing effects and therapeutic potential. Metabolites. 2023;13:27611–6. https://doi.org/10.3390/metabo13020276
Wang Q, Jin M, Liu Y, Sun L, Lu B, Zhao L, et al. Synthesis, characterization and in vitro antiproliferative effects of pentacyclic triterpenoids. Med Chem Res. 2021;30:2055–68. https://doi.org/10.1007/s00044-021-02795-6
Majeed M, Nagabhushanam K, Bani S, Choudhury AK. Highly oxygenated 11‐keto‐β‐boswellic acid analogues and their antiinflammatory potential. ChemistrySelect. 2018;3:3087–91. https://doi.org/10.1002/slct.201800094
Dong MS, Jung SH, Kim HJ, Kim JR, Zhao LX, Lee ES, et al. Structure-related cytotoxicity and antihepatofibric effect of asiatic acid derivatives in rat hepatic stellate cell-line, HSC-T6. Arch Pharm Res. 2004;27:512–7. https://doi.org/10.1007/BF02980124
Article CAS PubMed Google Scholar
Zhao CH, Xu J, Zhang YQ, Zhao LX, Feng B. Inhibition of human enterovirus 71 replication by pentacyclic triterpenes and their novel synthetic derivatives. Chem Pharm Bull. 2014;62:764–71. https://doi.org/10.1248/cpb.c14-00088
Huang RZ, Liang GB, Li MS, Fang YL, Zhao SF, Zhou MM, et al. Synthesis and discovery of asiatic acid based 1,2,3-triazole derivatives as antitumor agents blocking NF-κB activation and cell migration. MedChemComm. 2019;10:584–97. https://doi.org/10.1039/C8MD00620B
Article CAS PubMed PubMed Central Google Scholar
Jin YT, Qi YQ, Jin M, Sun JF, Diao SB, Zhou W, et al. Synthesis, antitumor and antibacterial activities of cordycepin derivatives. J Asian Nat Prod Res. 2021;24:849–59. https://doi.org/10.1080/10286020.2021.1982907
Comments (0)